EventHealthNovember 19, 2026

Merck, Isomorphic Labs partner on oncology drug discovery

Read original source →statnews.com

Merck and Isomorphic Labs will collaborate to find small molecule candidates against an undisclosed oncology target of "strategic importance," pairing Isomorphic's drug design engine with Merck's wet lab data. Merck handles preclinical and clinical development, manufacturing, and commercialization.

1 source

More stories today

Open the live feed